Eisai Co (TSE:4523) Accounts Payable & Accrued Expense : 円62,540 Mil (As of Dec. 2023)

View and export this data going back to 1961. Start your Free Trial

What is Eisai Co Accounts Payable & Accrued Expense?

Eisai Co's quarterly accounts payable & accrued expense increased from Jun. 2023 (円68,071 Mil) to Sep. 2023 (円69,262 Mil) but then declined from Sep. 2023 (円69,262 Mil) to Dec. 2023 (円62,540 Mil).

Eisai Co's annual accounts payable & accrued expense increased from Mar. 2021 (円97,070 Mil) to Mar. 2022 (円114,942 Mil) but then declined from Mar. 2022 (円114,942 Mil) to Mar. 2023 (円89,049 Mil).

Eisai Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Eisai Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eisai Co Accounts Payable & Accrued Expense Chart

Eisai Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

85,693.00

82,234.00

97,070.00

114,942.00

89,049.00

Eisai Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															75,765.00	89,049.00	68,071.00	69,262.00	62,540.00

Eisai Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Eisai Co (TSE:4523) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eisai Co Ltd (TSE:4523) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

ESAIY:USA ESALF:USA EII:Germany

Address

4-6-10 Koishikawa, Bunkyo-ku, Tokyo, JPN, 112-8088

Website

http://www.eisai.co.jp

Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of a pharmaceutical business and other businesses. The pharmaceutical business is categorized by region, including Japan, Americas, China, Asia, and Europe, Middle East, and Africa. Eisai also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived by its Japanese pharmaceutical business, followed by its Americas pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.

Eisai Co (TSE:4523) Headlines

No Headlines